Genetic risk for Alzheimer’s disease is concentrated in specific macrophage and microglial transcriptional networks
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-994X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Genetic risk for Alzheimer’s disease is concentrated in specific macrophage and microglial transcriptional networks ; volume:10 ; number:1 ; day:26 ; month:2 ; year:2018 ; pages:1-10 ; date:12.2018
Genome medicine ; 10, Heft 1 (26.2.2018), 1-10, 12.2018
- Urheber
-
Tansey, Katherine E.
- Beteiligte Personen und Organisationen
-
Cameron, Darren
Hill, Matthew J.
SpringerLink (Online service)
- DOI
-
10.1186/s13073-018-0523-8
- URN
-
urn:nbn:de:1111-201804251150
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tansey, Katherine E.
- Cameron, Darren
- Hill, Matthew J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Diverse human astrocyte and microglial transcriptional responses to Alzheimer’s pathology
Microglial Activation in Alzheimer’s Disease
Microglial immunophenotype in dementia with Alzheimer’s pathology
Microglial IKKß Defiency Ameliorates Alzheimer´s Disease-Realted Symptoms and Pathology
Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration
Ultrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology
Müller cell degeneration and microglial dysfunction in the Alzheimer’s retina
Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
Cytokine signaling convergence regulates the microglial state transition in Alzheimer’s disease
Phosphoinositides signaling modulates microglial actin remodeling and phagocytosis in Alzheimer’s disease
Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer’s disease
Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer’s pathology
Diverse human astrocyte and microglial transcriptional responses to Alzheimer’s pathology
Microglial Activation in Alzheimer’s Disease
Microglial immunophenotype in dementia with Alzheimer’s pathology
Microglial IKKß Defiency Ameliorates Alzheimer´s Disease-Realted Symptoms and Pathology
Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration
Ultrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology
Müller cell degeneration and microglial dysfunction in the Alzheimer’s retina
Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
Cytokine signaling convergence regulates the microglial state transition in Alzheimer’s disease
Phosphoinositides signaling modulates microglial actin remodeling and phagocytosis in Alzheimer’s disease
Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer’s disease
Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer’s pathology
Diverse human astrocyte and microglial transcriptional responses to Alzheimer’s pathology
Microglial Activation in Alzheimer’s Disease
Microglial immunophenotype in dementia with Alzheimer’s pathology
Microglial IKKß Defiency Ameliorates Alzheimer´s Disease-Realted Symptoms and Pathology
Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration
Ultrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology
Müller cell degeneration and microglial dysfunction in the Alzheimer’s retina
Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
Cytokine signaling convergence regulates the microglial state transition in Alzheimer’s disease
Phosphoinositides signaling modulates microglial actin remodeling and phagocytosis in Alzheimer’s disease
Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer’s disease